Yüklüyor......
Quantitative Interrogation of the Human Kinome Perturbed by Two BRAF Inhibitors
Oncogenic BRAF mutations contribute to the development of a number of cancers, and small-molecule BRAF inhibitors have been approved by the Food and Drug Administration (FDA) for anticancer therapy. In this study, we employed two targeted quantitative proteomics approaches for monitoring separately...
Kaydedildi:
| Yayımlandı: | J Proteome Res |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6939617/ https://ncbi.nlm.nih.gov/pubmed/30994353 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.jproteome.9b00134 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|